Gadolinium News and Research

RSS

European Commission grants marketing authorization for NEZGLYAL® (leriglitazone), the first pharmacological treatment approved for cerebral adrenoleukodystrophy (cALD), a rare neurodegenerative disease

Neuraxpharm Group and Minoryx Therapeutics, today announce that the European Commission (EC) has granted marketing authorization under exceptional circumstances for NEZGLYAL® (leriglitazone), an orally bioavailable, brain penetrating, selective PPAR gamma agonist, as a treatment for male cALD patients, aged 2-12 years with Gadolinium (Gd)-negative brain lesions.

26 Sep 2026

Lanthanide carriers advance next generation biomedical imaging and theranostics

Lanthanide carriers could help define the next generation of biomedical imaging and fast-track the emerging field of theranostics-approaches that link diagnostic imaging with treatment selection, delivery, or monitoring.

30 Jul 2026

Synthetic protein hybrid offers promising treatment for liver diseases

The research group led by CIC biomaGUNE's Ikerbasque Research Professor Aitziber L. Cortajarena has developed an innovative anti-fibrotic and anti-tumor treatment by binding a synthetic protein to gold nanoclusters (small aggregates of approximately 6 atoms of gold).

23 Jun 2026

Lightweight polymer protects X-ray workers from chronic pain and lead toxicity

A light, flexible polymer material developed at the University of Waterloo could replace the lead in heavy X-ray aprons, providing the same protection from harmful radiation while reducing their weight by almost 90 per cent.

8 Jun 2026

Newly developed smart molecules offer a safer and more precise approach to cancer care

Researchers at NYU Abu Dhabi have developed smart molecules that can both detect and treat cancer, offering a safer and more precise approach to care.

7 Apr 2026

Scientists turn red blood cells into long-lasting drug and imaging carriers in mice

A new preclinical study shows that red blood cells can be tagged in vivo and used as long-lasting carriers for imaging agents and therapies, opening a new route for safer drug delivery and vascular imaging.

23 Mar 2026

OSU researchers design a highly effective, low-dose, manganese-MOF MRI agent

Scientists at Oregon State University have filed a patent on a design for a new magnetic resonance imaging contrast agent with the potential to outperform current agents while being less toxic to patients and more environmentally friendly.

7 Nov 2025

AI-powered virtual MRI imaging enables safer and more accurate tumor detection

During magnetic resonance imaging (MRI) procedures, contrast agents, such as the rare metal gadolinium, can pose potential health risks.

13 Aug 2025

Enhancing early breast cancer diagnosis through modern imaging technologies

Breast cancer remains a leading cause of cancer-related mortality globally, underscoring the critical need for early detection to improve survival rates and reduce treatment invasiveness.

28 May 2025

Micro-ultrasound proves as effective as MRI in prostate cancer diagnosis

Biopsies guided by high resolution ultrasound are as effective as those using MRI in diagnosing prostate cancer, an international clinical trial has shown.

24 Mar 2025

New 3D imaging technology could revolutionize medical diagnostics

New technology developed by researchers at the University of Houston could revolutionize medical imaging and lead to faster, more precise and more cost-effective alternatives to traditional diagnostic methods.

25 Feb 2025

Stem cell-derived heart patches show promise for heart failure treatment

Innovative muscle patches derived from stem cells demonstrate efficacy in heart repair, improving function in primates and a human patient, with trials ahead.

30 Jan 2025

Researchers explore patient's perceptions of AI in radiology

AI-powered MRIs could cut the potentially toxic dyes used in traditional MRIs by up to 80 percent, but will patients embrace AI-driven brain scans?

10 Dec 2024

Researchers develop the first polymer-based therapeutic for Huntington’s disease

Breakthrough polymer-based therapy shows promise in reversing Huntington's disease symptoms by preventing toxic protein clumps and enhancing neuronal survival.

4 Nov 2024

Study challenges early intervention for asymptomatic aortic stenosis

The EVOLVED trial found that early aortic valve intervention in patients with asymptomatic severe aortic stenosis (AS) and mid-wall myocardial fibrosis on magnetic resonance imaging did not reduce the incidence of the composite primary endpoint of all-cause death or unplanned aortic stenosis hospitalization compared with guideline-directed conservative management.

30 Oct 2024

New study confirms brain's waste-clearance pathways in humans

Scientists have long theorized about a network of pathways in the brain that are believed to clear metabolic proteins that would otherwise build up and potentially lead to Alzheimer's and other forms of dementia. But they had never definitively revealed this network in people - until now.

7 Oct 2024

COVID-19 mRNA vaccine linked to myocardial scarring in adolescents and young adults

The study investigates COVID-19 vaccine-related myocarditis in adolescents, revealing clinical characteristics and risks of myocardial injury in young adults.

11 Sep 2024

New dual-purpose contrast agent revolutionizes PET and MRI integration for enhanced diagnosis

A research team from IOCB Prague, working in collaboration with the University of Tübingen, Germany, and the Faculty of Science, Charles University, has developed a new type of contrast agent that can be used in both magnetic resonance imaging (MRI) and positron emission tomography (PET).

5 Aug 2024

Enhancing heart failure management with cardiac magnetic resonance imaging

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Heart failure (HF) is a clinical syndrome with a wide variety of clinical presentations, pathophysiologies, and natural histories.

4 Jul 2024

Newly discovered cause for asthma sparks hope for treatment

Scientists at King's College London have discovered a new cause for asthma that sparks hope for treatment that could prevent the life-threatening disease.

4 Apr 2024